中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Nanotechnology-based strategies for treatment of ocular disease

文献类型:期刊论文

作者Weng, Yuhua1,2,3; Liu, Juan2,3; Jin, Shubin2,3; Guo, Weisheng2,3; Liang, Xingjie2,3; Hua, Zhongbo1
刊名Acta pharmaceutica sinica b
出版日期2017-05-01
卷号7期号:3页码:281-291
关键词Nanosystems Nanocarrier Eye Ocular disease Ocular drug delivery Therapy Diagnosis
ISSN号2211-3835
DOI10.1016/j.apsh.2016.09.001
通讯作者Guo, weisheng(guows@nanoctr.cn) ; Liang, xingjie(liangxj@nanoctr.cn) ; Hua, zhongbo(huzq@ucas.ac.cn)
英文摘要Ocular diseases include various anterior and posterior segment diseases. due to the unique anatomy and physiology of the eye, efficient ocular drug delivery is a great challenge to researchers and pharmacologists. although there are conventional noninvasive and invasive treatments, such as eye drops, injections and implants, the current treatments either suffer from low bioavailability or severe adverse ocular effects. alternatively, the emerging nanoscience and nanotechnology are playing an important role in the development of novel strategies for ocular disease therapy. various active molecules have been designed to associate with nanocarriers to overcome ocular barriers and intimately interact with specific ocular tissues. in this review, we highlight the recent attempts of nanotechnology-based systems for imaging and treating ocular diseases, such as corneal diseases, glaucoma, retina diseases, and choroid diseases. although additional work remains, the progress described herein may pave the way to new, highly effective and important ocular nanomedicines. (c) 2017 chinese pharmaceutical association and institute of materia medica, chinese academy of medical sciences. production and hosting by elsevier b.v. this is an open access article under the cc by-nc-nd license
WOS关键词PIGMENT EPITHELIAL-CELLS ; GANCICLOVIR OPHTHALMIC GEL ; LOADED BIODEGRADABLE NANOPARTICLES ; OPTICAL COHERENCE TOMOGRAPHY ; HUMAN RETINOBLASTOMA CELLS ; DRUG-DELIVERY ; IN-VIVO ; PHOTODYNAMIC THERAPY ; SIRNA DELIVERY ; CORNEAL
WOS研究方向Pharmacology & Pharmacy
WOS类目Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000417187900003
出版者INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
URI标识http://www.irgrid.ac.cn/handle/1471x/2177808
专题高能物理研究所
通讯作者Guo, Weisheng; Liang, Xingjie; Hua, Zhongbo
作者单位1.Univ Chinese Acad Sci, Coll Mat Sci & Optoelect, Beijing 100049, Peoples R China
2.Chinese Acad Sci, Ctr Excellence Nanosci, Lab Controllable Nanopharm, Beijing 100190, Peoples R China
3.Natl Ctr Nanosci & Technol China, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China
推荐引用方式
GB/T 7714
Weng, Yuhua,Liu, Juan,Jin, Shubin,et al. Nanotechnology-based strategies for treatment of ocular disease[J]. Acta pharmaceutica sinica b,2017,7(3):281-291.
APA Weng, Yuhua,Liu, Juan,Jin, Shubin,Guo, Weisheng,Liang, Xingjie,&Hua, Zhongbo.(2017).Nanotechnology-based strategies for treatment of ocular disease.Acta pharmaceutica sinica b,7(3),281-291.
MLA Weng, Yuhua,et al."Nanotechnology-based strategies for treatment of ocular disease".Acta pharmaceutica sinica b 7.3(2017):281-291.

入库方式: iSwitch采集

来源:高能物理研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。